Formulation and physicochemical characterization of poly(epsilon-caprolactone) nanoparticles loaded with ftorafur and diclofenac sodium.
Even though conventional pharmacotherapy has been demonstrated to display very efficient activity against a wide variety of diseases, several active agents (e.g., anti-tumor drugs and non-steroidal anti-inflammatory drugs) are generally needed to be administered at high doses to elicit the required therapeutic action, simultaneously leading to severe side effects. This fact is usually due to unfavourable pharmacokinetic profiles (poor biological half-life) and to the possibility of induction of resistance. In order to increase the therapeutic activity of ftorafur and diclofenac sodium along with an overcome of their important drawbacks, we investigated their formulation into a colloidal carrier based on the biodegradable polymer poly(epsilon-caprolactone). Two drug loading methods were studied: (i) surface adsorption in already formed nanoparticles after incubation in a drug solution; (ii) drug addition before interfacial polymer disposition leading to drug entrapment into the polymeric network. We hypothesized that such nanocarrier possessed very significant characteristics (e.g., unusually high drug loading and low burst release), suggesting their potential application for efficient drug delivery to targeted sites.
Arias
José L
JL
Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, Spain. jlarias@ugr.es
López-Viota
Margarita
M
Sáez-Fernández
Eva
E
Ruiz
M Adolfina
MA
D000327:Adsorption / Q000187:drug effects; D055598:Chemical Phenomena / Q000187:drug effects; D002626:Chemistry, Pharmaceutical; D004008:Diclofenac / Q000494:pharmacology*; D004586:Electrophoresis; D053758:Nanoparticles / Q000737:chemistry* / Q000648:ultrastructure; D010316:Particle Size; D011091:Polyesters / Q000737:chemistry*; D005641:Tegafur / Q000494:pharmacology*
D011091:Polyesters; D004008:Diclofenac; D005641:Tegafur; C016240:polycaprolactone